EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Diagnosis, Prognosis, and Treatment of Triple-Negative Breast Cancer: A Review

Huan Jie, Wenhui Ma, Cong Huang

Breast Cancer: Targets and Therapy · 2025-03 · Volume 17 · 265-274

DOI: 10.2147/bctt.s516542 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Breast Cancer: Targets and Therapy, 2025-03. Verfasst von Huan Jie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, No. 926 hospital, Joint Logistics Support Force of PLA, Kaiyuan, Yunnan, 661699, People's Republic of China. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

chemotherapydiagnosisimmunotherapymolecular typingprognosistargeted therapytreatmenttriple-negative breast cancer

Autor:innen und Institutionen

  • Department of Oncology, No. 926 hospital, Joint Logistics Support Force of PLA, Kaiyuan, Yunnan, 661699, People's Republic of China.
  • Department of Radiology, No. 926 hospital, Joint Logistics Support Force of PLA, Kaiyuan, Yunnan, 661699, People's Republic of China.

Zitieren

APA

Jie, H., Ma, W., & Huang, C. (2025). Diagnosis, Prognosis, and Treatment of Triple-Negative Breast Cancer: A Review. Breast Cancer: Targets and Therapy, Volume 17, 265-274. https://doi.org/10.2147/bctt.s516542

Vancouver

Jie H, Ma W, Huang C. Diagnosis, Prognosis, and Treatment of Triple-Negative Breast Cancer: A Review. Breast Cancer: Targets and Therapy. 2025;Volume 17:265-274. doi:10.2147/bctt.s516542

BibTeX
@article{Jie2025,
  author = {Jie, Huan and Ma, Wenhui and Huang, Cong},
  title = {Diagnosis, Prognosis, and Treatment of Triple-Negative Breast Cancer: A Review},
  journal = {Breast Cancer: Targets and Therapy},
  year = {2025},
  volume = {Volume 17},
  pages = {265--274},
  doi = {10.2147/bctt.s516542}
}
Kostenlos starten →